Patient reported outcomes for anxiety. Sample Size 7674

Learn More:

Anxiety & Panic Disorders Health Center: Anxiety Disorders. (n.d.). WebMD. Retrieved from

Anxiety Disorders. (2015, May). National Institute of Mental Health. Retrieved from

Bluett, R.J., Gamble-George, J.C., Hermanson, D.J., Hartley, N.D., Marnett, L.J., and Patel, S. (2014). Central anandamide deficiency predicts stress-induced anxiety: behavioural reversal through endocannabinoid augmentation. Translational Psychiatry4(7), e408. Retrieved from

García-Gutiérrez, M.S., García-Bueno, B., Zoppi, S., Leza, J.C., and Manzanares, J. (2012, February). Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alternations in GABAA British Journal of Pharmacology, 165(4), 951-964. Retrieved from

García-Gutiérrez, M.S., and Manzanares, J. (2011, January). Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice. Journal of Pharmacology, 25(1), 111-120. Retrieved from

Moreira, F.A., Kaiser, N., Monory, K., and Lutz, B., (2008, January). Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacology, 54(1), 141-50. Retrieved from

Walsh, Z., Gonzalez, R., Crosby, K., Thiessmen, M.S., Carroll, C., and Bonn-Miller, M.O. (2016, October 12). Medical cannabis and mental health: A guided systematic review. Clinical Psychology Review, 51, 15-29. Retrieved from

Stay up to date with us!

Receive quarterly publications with Harvest Medicine announcements,
current events, & educational opportunities. You may unsubscribe at any time.